Evidence mapPaperPMID 30767786Full record

ArticleGenome medicine2019

Ten years of Genome Medicine.

Charles Auffray, Julian L Griffin, Muin J Khoury, James R Lupski, Matthias Schwab

Abstract readEditorialHistorical Article
In one paragraph

Article in Genome medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Observational
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Charles AuffrayEuropean Institute for Systems Biology and Medicine (EISBM), Vourles, France. cauffray@eisbm.org.
Julian L GriffinDepartment of Biochemistry and Cambridge Systems Biology Centre, University of Cambridge, Sanger Building, Tennis Court Road, Cambridge, CB2 1GA, UK.
Muin J KhouryOffice of Public Health Genomics, Centers for Disease Control and Prevention, Atlanta, GA, 30329, USA.
James R LupskiDepartment of Molecular and Human Genetics, Baylor College of Medicine, Baylor Plaza, Houston, TX, 77030, USA.
Matthias SchwabDr Margarete Fischer-Bosch Institute of Clinical Pharmacology, Auerbachstraße, 70376, Stuttgart, Germany.

Funding

STRUCTURAL VARIATION IN NEUROLOGICAL DISEASER35NS105078 · NINDS · BAYLOR COLLEGE OF MEDICINE · 2022 to 2025
$3.5M
Medical Research Council MC PC 13030Medical Research Council MC_PC_13030Medical Research Council MC_UP_A090_1006Medical Research Council MC UP A90 1006Medical Research Council MR/P011705/1Medical Research Council MR/P01836X/1Medical Research Council MR/P024416/1NHGRI NIH HHS UM1 HG006542NIGMS NIH HHS R01 GM106373NINDS NIH HHS R35 NS105078Wellcome Trust
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

GenomicsHuman GeneticsHistory, 21st CenturyHumansPeriodicals as Topic

Identifiers

PMID30767786
PMCPMC6376775

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.